FDA Inspection
Boiron, Inc.Boiron, Inc. – FDA Inspection, Jun 16, 2010
Record Details
This FDA Inspection record concerns Boiron, Inc., with an inspection on June 16, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Boiron, Inc.
- Inspection Date
- June 16, 2010
- Product Type
- Drugs
View Company Profile
ID · c7117ff2-fbe2-4d4d-b5cb-b7035298aab6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 671989
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.170(b)(1)Retention time of reserve samples, in general
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Boiron, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 10, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Boiron, Inc.
- FDA Inspection 907389 - 2014-12-10
- FDA Inspection 607798 - 2009-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.